Evaluation of molecular mechanisms of riboflavin anti-COVID-19 action reveals anti-inflammatory efficacy rather than antiviral activity

Evaluation of molecular mechanisms of riboflavin anti-COVID-19 action reveals anti-inflammatory efficacy rather than antiviral activity

Riboflavin (vitamin B2) is one of the most important water-soluble vitamins and a coenzyme involved in many biochemical processes. It has previously been shown that adjuvant therapy with flavin mononucleotide (a water-soluble form of riboflavin) correlates with normalization of clinically relevant i...

Full description

Saved in:
Bibliographic Details
Published in:Biochimica et biophysica acta. General subjects Vol. 1868; no. 5; p. 130582
Main Authors: Akasov, Roman A., Chepikova, Olga E., Pallaeva, Tatiana N., Gorokhovets, Neonila V., Siniavin, Andrei E., Gushchin, Vladimir A., Savvateeva, Lyudmila V., Vinokurov, Ivan A., Khochenkov, Dmitry A., Zamyatnin, Andrey A., Khaydukov, Evgeny V.
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 01-05-2024
Subjects:
Cytokines
Inflammation
PLpro protease
Riboflavin
SARS-CoV-2
Riboflavin
SARS-CoV-2
Inflammation
PLpro protease
Cytokines
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Riboflavin (vitamin B2) is one of the most important water-soluble vitamins and a coenzyme involved in many biochemical processes. It has previously been shown that adjuvant therapy with flavin mononucleotide (a water-soluble form of riboflavin) correlates with normalization of clinically relevant immune markers in patients with COVID-19, but the mechanism of this effect remains unclear. Here, the antiviral and anti-inflammatory effects of riboflavin were investigated to elucidate the molecular mechanisms underlying the riboflavin-induced effects. Riboflavin was evaluated for recombinant SARS-CoV-2 PLpro inhibition in an enzyme kinetic assay and for direct inhibition of SARS-CoV-2 replication in Vero E6 cells, as well as for anti-inflammatory activity in polysaccharide-induced inflammation models, including endothelial cells in vitro and acute lung inflammation in vivo. For the first time, the ability of riboflavin at high concentrations (above 50 μM) to inhibit SARS-CoV-2 PLpro protease in vitro was demonstrated; however, no inhibition of viral replication in Vero E6 cells in vitro was found. At the same time, riboflavin exerted a pronounced anti-inflammatory effect in the polysaccharide-induced inflammation model, both in vitro, preventing polysaccharide-induced cell death, and in vivo, reducing inflammatory markers (IL-1β, IL-6, and TNF-α) and normalizing lung histology. It is concluded that riboflavin reveals anti-inflammatory rather than antiviral activity for SARS-CoV-2 infection. Riboflavin could be suggested as a promising compound for the therapy of inflammatory diseases of broad origin. •Riboflavin inhibits the SARS-CoV-2 PLpro protease at concentrations above 50 μM.•Riboflavin prevents LPS-induced death of mouse SVEC-4-10 endothelial cells.•Riboflavin decreases inflammatory markers IL-1β, IL-6, and TNF-α levels in vivo.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0304-4165
1872-8006
DOI:10.1016/j.bbagen.2024.130582